Mucocutaneous drug reaction after treatment with Phosphatidylinositol-3-kinase inhibitor

Mucocutaneous drug reaction after treatment with Phosphatidylinositol-3-kinase inhibitor

Guardado en:
Detalles Bibliográficos
Autores principales: Tory Starzyk, MA, Rebecca Olsen, MS, David Baltazar, DO, Bridget Sledge, DO, Yebabe Mengesha, MD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
alpelisib
drug reaction
immune checkpoint inhibitor
mucocutaneous
PI3K inhibitor
Dermatology
RL1-803
Acceso en línea:https://doaj.org/article/b1c79f6a874c4efe8b8d4f63a8014437
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b1c79f6a874c4efe8b8d4f63a8014437
record_format dspace
spelling oai:doaj.org-article:b1c79f6a874c4efe8b8d4f63a80144372021-12-04T04:35:16ZMucocutaneous drug reaction after treatment with Phosphatidylinositol-3-kinase inhibitor2352-512610.1016/j.jdcr.2021.10.033https://doaj.org/article/b1c79f6a874c4efe8b8d4f63a80144372022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352512621008341https://doaj.org/toc/2352-5126Tory Starzyk, MARebecca Olsen, MSDavid Baltazar, DOBridget Sledge, DOYebabe Mengesha, MDElsevierarticlealpelisibdrug reactionimmune checkpoint inhibitormucocutaneousPI3K inhibitorDermatologyRL1-803ENJAAD Case Reports, Vol 19, Iss , Pp 25-27 (2022)
institution DOAJ
collection DOAJ
language EN
topic alpelisib
drug reaction
immune checkpoint inhibitor
mucocutaneous
PI3K inhibitor
Dermatology
RL1-803
spellingShingle alpelisib
drug reaction
immune checkpoint inhibitor
mucocutaneous
PI3K inhibitor
Dermatology
RL1-803
Tory Starzyk, MA
Rebecca Olsen, MS
David Baltazar, DO
Bridget Sledge, DO
Yebabe Mengesha, MD
Mucocutaneous drug reaction after treatment with Phosphatidylinositol-3-kinase inhibitor
format article
author Tory Starzyk, MA
Rebecca Olsen, MS
David Baltazar, DO
Bridget Sledge, DO
Yebabe Mengesha, MD
author_facet Tory Starzyk, MA
Rebecca Olsen, MS
David Baltazar, DO
Bridget Sledge, DO
Yebabe Mengesha, MD
author_sort Tory Starzyk, MA
title Mucocutaneous drug reaction after treatment with Phosphatidylinositol-3-kinase inhibitor
title_short Mucocutaneous drug reaction after treatment with Phosphatidylinositol-3-kinase inhibitor
title_full Mucocutaneous drug reaction after treatment with Phosphatidylinositol-3-kinase inhibitor
title_fullStr Mucocutaneous drug reaction after treatment with Phosphatidylinositol-3-kinase inhibitor
title_full_unstemmed Mucocutaneous drug reaction after treatment with Phosphatidylinositol-3-kinase inhibitor
title_sort mucocutaneous drug reaction after treatment with phosphatidylinositol-3-kinase inhibitor
publisher Elsevier
publishDate 2022
url https://doaj.org/article/b1c79f6a874c4efe8b8d4f63a8014437
work_keys_str_mv AT torystarzykma mucocutaneousdrugreactionaftertreatmentwithphosphatidylinositol3kinaseinhibitor
AT rebeccaolsenms mucocutaneousdrugreactionaftertreatmentwithphosphatidylinositol3kinaseinhibitor
AT davidbaltazardo mucocutaneousdrugreactionaftertreatmentwithphosphatidylinositol3kinaseinhibitor
AT bridgetsledgedo mucocutaneousdrugreactionaftertreatmentwithphosphatidylinositol3kinaseinhibitor
AT yebabemengeshamd mucocutaneousdrugreactionaftertreatmentwithphosphatidylinositol3kinaseinhibitor
_version_ 1718372935368966144

Ejemplares similares